Wells Fargo Maintains Equal-Weight on Merck & Co, Lowers Price Target to $125
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Mohit Bansal maintains an Equal-Weight rating on Merck & Co (NYSE:MRK) but lowers the price target from $140 to $125.
July 31, 2024 | 4:07 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Wells Fargo analyst Mohit Bansal maintains an Equal-Weight rating on Merck & Co but lowers the price target from $140 to $125.
The lowered price target from $140 to $125 by Wells Fargo suggests a less optimistic outlook for Merck & Co, which could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100